Anchen Pharmaceuticals has received FDA approval to market a generic version of GlaxoSmithKline’s Wellbutrin XL (bupropion hydrochloride) Extended-Release Tablets. The product is indicated for the treatment of major depressive disorder. Bupropion hydrochloride extended-release tablets will be available in 150mg and 300mg dosage strengths.

For more information call (949) 837-6178 or visit www.anchen.com.